Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer’s Disease-Reference-Cited by-同舟云学术

Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer’s Disease

Published:2020-03-26 Issue:5 Volume:17 Page:1527-1537
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Jin Liang¹,Pan Yijun¹^ORCID,Tran Natalie Lan Linh¹,Polychronopoulos Leon N.¹,Warrier Aparna¹,Brouwer Kim L. R.²^ORCID,Nicolazzo Joseph A.¹^ORCID

Affiliation:

1. Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia

2. Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

Funder

Alzheimer's Association

Bethlehem Griffiths Research Foundation

National Institute of General Medical Sciences

PharmAlliance

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.9b01227

Reference59 articles.

1. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention

2. Effects of Hypertension and Hypercholesterolemia on Cognitive Functioning in Patients With Alzheimer Disease

3. Diabetes and Alzheimer's Disease: Mechanisms and Nutritional Aspects

4. Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data

5. Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer’s Disease

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma, brain and spinal cord concentrations of caffeine are reduced in the SOD1G93A mouse model of amyotrophic lateral sclerosis following oral administration;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

2. Sex-Dependent Changes to the Intestinal and Hepatic Abundance of Drug Transporters and Metabolizing Enzymes in the SOD1^G93A Mouse Model of Amyotrophic Lateral Sclerosis;Molecular Pharmaceutics;2024-02-28

3. Characterization, optimization, and in vitro evaluation of cholesterol-free liposomes;Journal of Drug Delivery Science and Technology;2023-06

4. Myelin in Alzheimer’s disease: culprit or bystander?;Acta Neuropathologica Communications;2023-03-31

5. Altered Blood–Brain Barrier Dynamics in the C9orf72 Hexanucleotide Repeat Expansion Mouse Model of Amyotrophic Lateral Sclerosis;Pharmaceutics;2022-12-14